Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers May 26, 2017
Pharmacy Choice - Pharmacy News - May 26, 2017

Pharmacy News

Today's Pharmaceutical and Pharmacy News
Daily News Topic:

FDA News
5/26/17 - Data from M.R. Geier et al Provide New Insights into Vaccines [Quadrivalent human papillomavirus vaccine and autoimmune adverse events: a...
Data from M.R. Geier et al Provide New Insights into Vaccines. According to news originating from Silver Spring, Maryland, by NewsRx correspondents, research stated, "Gardasil is a quadrivalent human papillomavirus vaccine that was approved for use by the US Food and Drug Administration in June 2006. HPV4 vaccine is routinely recommended for admini
5/26/17 - FDA approves Sun Pharmas tildrakizumab for moderate-to-severe plaque psoriasis [Sudan Tribune]
Indian company Sun Pharmaceutical Industries has received the US Food and Drug Administration approval of the Biologics License Application for tildrakizumab to treat patients with moderate-to-severe plaque psoriasis. The FDA filing acceptance follows acceptance of the regulatory filing of tildrakizumab by the European Medicines Agency in March...
5/26/17 - GNW-News: Novartis receives FDA approval for expanded use of Zykadia® in first-line ALK-positive metastatic non-small cell lung cancer (NSCLC) (english)
Novartis receives FDA approval for expanded use of Zykadia ® in first-line ALK-positive metastatic non-small cell lung cancer. Novartis International AG/ Novartis receives FDA approval for expanded use of Zykadia ® in first-line ALK-positive metastatic non-small cell lung cancer. Basel, May 26, 2017- Novartis today announced the US Food and Drug.
5/26/17 - Novartis receives FDA approval for expanded use of Zykadia® in first-line ALK-positive metastatic non-small cell lung cancer (NSCLC)
--Novartis today announced the US Food and Drug Administration approved the expanded use of Zykadia ® to include the first-line treatment of patients with metastatic non-small cell lung cancer whose tumors are anaplastic lymphoma kinase- positive, as detected by an FDA- approved test. In January 2017, the FDA granted Zykadia Breakthrough Therapy..
5/25/17 - Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals
FOR FURTHER INFORMATION CONTACT: Ila S. Mizrachi, FDA PRA Staff, Office of Operations, Food and Drug Administration, Three White Flint North, 11601 Landsdown St., North Bethesda, MD 20852, 301-796-7726, PRAStaff@fda.hhs.gov. SUPPLEMENTARY INFORMATION: The following is a list of FDA information collections recently approved by OMB under section 3507
5/25/17 - Blog Coverage Merck's KEYTRUDA Becomes First Cancer Drug to be Approved by FDA Based on a Common Biomarker Instead of the Location of the Tumor
Upcoming AWS Coverage on Retrophin Post-Earnings Results. LONDON, UK/ ACCESSWIRE/ May 25, 2017/ Active Wall St. blog coverage looks at the headline from Merck& Co., Inc. as the Company announced that the US Food and Drug Administration has granted accelerated approval to a treatment for patients whose cancers have a specific genetic feature.

Chain Drug Review
Chain Drug Review Magazine Chain Drug Review, established in 1978 and published 21 times a year, is recognized as the premier news publication serving the entire chain drug store industry.
Featured Article from Chain Drug Review:
AWP suit settlement appealed
The National Association of Chain Drug Stores has appealed a U.S. District Court’s approval of settlements in the First DataBank Inc. and Medi-Span Inc. lawsuit. »read more

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Telepharmacy- Remote Delivery of Pharmacy Services
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415